iScience (Aug 2023)
Spatiotemporally organized immunomodulatory response to SARS-CoV-2 virus in primary human broncho-alveolar epithelia
- Diana Cadena Castaneda,
- Sonia Jangra,
- Marina Yurieva,
- Jan Martinek,
- Megan Callender,
- Matthew Coxe,
- Angela Choi,
- Juan García-Bernalt Diego,
- Jianan Lin,
- Te-Chia Wu,
- Florentina Marches,
- Damien Chaussabel,
- Peter Yu,
- Andrew Salner,
- Gabrielle Aucello,
- Jonathan Koff,
- Briana Hudson,
- Sarah E. Church,
- Kara Gorman,
- Esperanza Anguiano,
- Adolfo García-Sastre,
- Adam Williams,
- Michael Schotsaert,
- Karolina Palucka
Affiliations
- Diana Cadena Castaneda
- The Jackson Laboratory for Genomic Medicine, Farmington, CT 06032, USA
- Sonia Jangra
- Department of Microbiology, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA; Global Health and Emerging Pathogens Institute, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA
- Marina Yurieva
- The Jackson Laboratory for Genomic Medicine, Farmington, CT 06032, USA
- Jan Martinek
- The Jackson Laboratory for Genomic Medicine, Farmington, CT 06032, USA
- Megan Callender
- The Jackson Laboratory for Genomic Medicine, Farmington, CT 06032, USA
- Matthew Coxe
- The Jackson Laboratory for Genomic Medicine, Farmington, CT 06032, USA
- Angela Choi
- Department of Microbiology, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA; Global Health and Emerging Pathogens Institute, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA
- Juan García-Bernalt Diego
- Department of Microbiology, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA; Global Health and Emerging Pathogens Institute, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA
- Jianan Lin
- The Jackson Laboratory for Genomic Medicine, Farmington, CT 06032, USA
- Te-Chia Wu
- The Jackson Laboratory for Genomic Medicine, Farmington, CT 06032, USA
- Florentina Marches
- The Jackson Laboratory for Genomic Medicine, Farmington, CT 06032, USA
- Damien Chaussabel
- The Jackson Laboratory for Genomic Medicine, Farmington, CT 06032, USA
- Peter Yu
- Hartford HealthCare Cancer Institute, Hartford, CT 06102, USA
- Andrew Salner
- Hartford HealthCare Cancer Institute, Hartford, CT 06102, USA
- Gabrielle Aucello
- The Jackson Laboratory for Genomic Medicine, Farmington, CT 06032, USA
- Jonathan Koff
- Adult Cystic Fibrosis Program, Yale University, New Haven, CT 06519, USA
- Briana Hudson
- Nanostring Technologies, Translational Sciences, Seattle, WA 98109, USA
- Sarah E. Church
- Nanostring Technologies, Translational Sciences, Seattle, WA 98109, USA
- Kara Gorman
- Nanostring Technologies, Translational Sciences, Seattle, WA 98109, USA
- Esperanza Anguiano
- Nanostring Technologies, Translational Sciences, Seattle, WA 98109, USA
- Adolfo García-Sastre
- Department of Microbiology, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA; Global Health and Emerging Pathogens Institute, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA; Department of Medicine, Division of Infectious Diseases, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA; The Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA; Department of Pathology, Molecular and Cell-Based Medicine, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA
- Adam Williams
- The Jackson Laboratory for Genomic Medicine, Farmington, CT 06032, USA
- Michael Schotsaert
- Department of Microbiology, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA; Global Health and Emerging Pathogens Institute, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA
- Karolina Palucka
- The Jackson Laboratory for Genomic Medicine, Farmington, CT 06032, USA; Corresponding author
- Journal volume & issue
-
Vol. 26,
no. 8
p. 107374
Abstract
Summary: The COVID-19 pandemic continues to be a health crisis with major unmet medical needs. The early responses from airway epithelial cells, the first target of the virus regulating the progression toward severe disease, are not fully understood. Primary human air-liquid interface cultures representing the broncho-alveolar epithelia were used to study the kinetics and dynamics of SARS-CoV-2 variants infection. The infection measured by nucleoprotein expression, was a late event appearing between day 4–6 post infection for Wuhan-like virus. Other variants demonstrated increasingly accelerated timelines of infection. All variants triggered similar transcriptional signatures, an “early” inflammatory/immune signature preceding a “late” type I/III IFN, but differences in the quality and kinetics were found, consistent with the timing of nucleoprotein expression. Response to virus was spatially organized: CSF3 expression in basal cells and CCL20 in apical cells. Thus, SARS-CoV-2 virus triggers specific responses modulated over time to engage different arms of immune response.